Angiogenesis


During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
B7157 OGT 2115Target: HeparanasesSummary: Heparanase inhibitor -
B7741 BIO 51921 CitationSummary: α4β1 inhibitor -
B6106 Daprodustat(GSK1278863)Summary: HIF-prolyl hydroxylase inhibitor -
B6185 ACP-196Target: BTKSummary: irreversible BTK inhibitor -
C4321 Octyl-α-ketoglutarateSummary: prolyl hydroxylases (PHD) activator -
C4377 Adaptaquin1 CitationSummary: HIF-prolyl hydroxylase-2 (PHD2) inhibitor -
C4752 JNJ-42041935Summary: Hypoxia-inducible factor (HIF) prolyl hydroxylase (PHD) inhibitor -
B2298 Plinabulin (NPI-2358)Target: Vascular Disrupting Agents (VDA)Summary: vascular disrupting agent -
B1115 BAY 87-2243Target: Hypoxia Inducible Factors (HIFs)Summary: HIF-1 inhibitor,potent and selective -
A3001 PCI-32765 (Ibrutinib)7 CitationSummary: Bruton's tyrosine kinase (BTK) inhibitor

